About CardieX
CardieX is a company based in Sydney (Australia) founded in 1994. CardieX has completed 1 acquisition, including Blumio. CardieX offers products and services including SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2. CardieX operates in a competitive market with competitors including AliveCor, iRhythm Tech, Imperative Care, Aktiia and ZOLL AEDs, among others.
- Headquarter Sydney, Australia
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardiex Limited
-
Annual Revenue
$2.35 M (USD)-67.44as on Jun 30, 2025
-
Net Profit
-$8.74 M (USD)-95.49as on Jun 30, 2025
-
EBITDA
-$9.59 M (USD)-129.78as on Jun 30, 2025
-
Latest Funding Round
$4.5 M (USD), Post-IPO
Aug 22, 2022
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CardieX
CardieX is a publicly listed company on the ASX with ticker symbol CDX in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CardieX
CardieX offers a comprehensive portfolio of products and services, including SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2.
Noninvasive tool for assessing arterial and cardiovascular health.
Platform for cardiovascular health data and remote monitoring.
Device for tracking blood pressure and vascular health metrics.
People of CardieX
Unlock access to complete
Unlock access to complete
Funding Insights of CardieX
Investors in CardieX
CardieX has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include C2 Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by C2 Ventures in early-stage tech startups.
|
Locked | Locked | Locked |
Investor details for CardieX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CardieX
CardieX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Blumio.
Investment portfolio details for CardieX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contactless blood pressure monitor
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for CardieX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CardieX
Detailed financials for CardieX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardiex Comparisons
Peer comparison for CardieX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CardieX
CardieX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AliveCor, iRhythm Tech, Imperative Care, Aktiia and ZOLL AEDs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Access catheters for neurovascular stroke treatment are provided.
|
|
| Locked | Locked | Locked |
Offers wearable technology for 24/7 blood pressure tracking and app-based data analysis.
|
|
| Locked | Locked | Locked |
Medical devices and software for emergency care are developed.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
Detailed competitors of CardieX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardiex
Complete news archive for CardieX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CardieX
CardieX was founded in 1994 and raised its 1st funding round 28 years after it was founded.
CardieX is headquartered in Sydney, Australia. It is registered at Sydney, New South Wales, Australia.
Annual revenue of CardieX is $2.35M as on Jun 30, 2025.
CardieX was founded in 1994 in Sydney, Australia, and operates in the cardiac health sector. Digital and device-based solutions are offered, including an FDA-approved device for measuring blood pressure and cardiovascular risk parameters. The AtCor medical device is provided for detecting target organ damage and managing cardiovascular and renal diseases. Wearable smart devices are also supplied to identify risks for hypertension, cardiovascular disease, and kidney-related conditions.
CardieX's top competitors include AliveCor, iRhythm Tech and Imperative Care.
CardieX offers SphygmoCor XCEL, CONNEQT Pulse, and Oscar 2.
Yes, CardieX is publicly traded on ASX under the ticker symbol CDX.
CardieX has made 1 acquisition, including Blumio.
CardieX has 1 investor. Key investors include C2 Ventures.
The ticker symbol of CardieX is CDX on ASX.